Service Corporation International (SCI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 Feb, 2026Executive summary
Adjusted EPS for Q4 2025 was $1.14, up 8% year-over-year; full-year adjusted EPS was $3.85, up 9% year-over-year.
Revenue grew 2% in Q4 2025 and 3% for the full year, driven by both funeral and cemetery segments.
Net income attributable to common stockholders for Q4 2025 was $159.4 million.
Strong preneed sales production and disciplined capital deployment supported growth and shareholder returns.
Lower share count and reduced interest expense contributed positively to EPS growth.
Financial highlights
Q4 2025 revenue: $1,111.5M (up from $1,093.0M in Q4 2024); full year: $4,309.2M (up from $4,186.4M).
Q4 comparable funeral revenues rose by $3 million (<1%), driven by 3.2% growth in average revenue per service, offset by a 1.9% decline in funeral services performed.
Adjusted operating cash flow for Q4 was $213 million; full-year 2025 was $966 million, up 11% from 2024 (excluding cash taxes and special items).
Free cash flow for Q4 2025 was $106.7 million; full-year 2025 was $637.3 million.
Funeral gross profit declined by $4 million; gross margin fell 70 bps to ~21% due to higher recognized selling compensation.
Outlook and guidance
2026 adjusted EPS guidance: $4.05–$4.35, representing 5%–13% growth, with a midpoint of 9%.
2026 net cash from operations (excluding special items and cash taxes): $1,125M–$1,185M.
Maintenance CapEx for 2026 expected at $325 million.
Funeral segment: flat to slightly down volume, average revenue per case to grow at inflationary rates, margin expansion of 20–60 bps.
Cemetery segment: pre-need sales production to grow low- to mid-single digits, revenue up 2%–5%, margin expansion of 30–60 bps.
Latest events from Service Corporation International
- Urban network, pre-need backlog, and tech-driven efficiency fuel growth and future outlook.SCI
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Earnings growth, robust M&A, and tech-driven efficiency position the business for strong future gains.SCI
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20253 Feb 2026 - Normalized growth, margin expansion, and evolving cremation trends shape the outlook.SCI
BofA Securities Leveraged Finance Conference 20253 Feb 2026 - Q2 revenue up, adjusted EPS down; strong cash flow and capital returns; guidance at lower end.SCI
Q2 20242 Feb 2026 - Q3 2024 delivered stable profits, strong cash flow, and record acquisitions for future growth.SCI
Q3 202417 Jan 2026 - Stabilized volumes, moderated cremation shifts, and strong pre-need sales drive 2026 growth.SCI
UBS Global Healthcare Conference 202513 Jan 2026 - Strong market position, robust cash flow, and strategic growth drive superior shareholder returns.SCI
Investor presentation13 Jan 2026 - Strong market position, robust returns, and growth driven by scale and preneed strategy.SCI
Investor presentation13 Jan 2026 - Industry leader with strong cash flow, superior returns, and 2025 EPS growth aligned with targets.SCI
Investor presentation13 Jan 2026